EGFR and non-small cell lung carcinoma: Preclinical studies have also revealed that the pro-EMT factor TWIST leads to inhibition of pro-apoptotic protein BCL2-interacting mediator of cell death (BIM) either by directly binding to its promoter or by inducing ZEB1 in EGFR-mutant NSCLC murine models [28,33].